Association of Different Obesity Phenotypes with Sarcopenia in Han Chinese Middle-Aged and Elderly with Type 2 Diabetes Individuals
Lanyu Lu,Bowei Liu,Yongfang Ma
DOI: https://doi.org/10.2147/DMSO.S398475
2023-03-22
Abstract:Lanyu Lu, 1 Bowei Liu, 2 Yongfang Ma 3 1 Department of Endocrinology and Metabolic Diseases, Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China; 2 Department of Endocrinology, The First Hospital of Qinhuangdao, Qinhuangdao, Hebei, People's Republic of China; 3 Department of Internal Medicine, Chengde Medical University, Chengde, Hebei, People's Republic of China Correspondence: Bowei Liu, Department of Endocrinology, The First Hospital of Qinhuangdao, Qinhuangdao, Hebei, People's Republic of China, Tel/Fax +86-335-5908603, Email Purpose: To investigate the relationship between different obesity phenotypes and sarcopenia in hospitalized Chinese patients with type 2 diabetes mellitus (T2DM). Methods: This cross-sectional study included 385 men. Anthropometric measurements including applied the determination method of Dual-energy X-ray absorptiometry (DXA) determination of limb skeletal muscle mass index (ASMI) and blood samples were analyzed. The people were divided into four groups according to body mass index (BMI) (≥ 24kg/m 2 ) and waist circumference (WC) (female ≥ 85cm, male ≥ 90cm). Group A (BMI and WC were normal), Group B (BMI was normal and high WC), Group C (high BMI and WC were normal), and Group D (BMI and WC were abnormal). Results: The prevalence rates of sarcopenia and abdominal obesity were 32.2% and 74.0%, respectively. The detection rate of lower ASMI decreased gradually from Group A to Group D(74.6% vs 68.3% vs 54.5% vs 51.6%, χ 2 =14.243, P=0.003). Logistic analysis showed that the risk of lower ASMI were decreased by 62.4% (95% CI: 0.149– 0.950, P = 0.039) in Group C and 68.8% (95% CI: 0.165– 0.593, P = 0.000) in Group D compared with Group A, respectively. The risk of lower ASMI were increased 4.153-fold (95% CI: 2.623– 6.576, P = 0.000) in male. Male (OR = 4.065, 95% CI: 2.246– 7.356, P = 0.000) and WC (OR = 1.053, 95% CI: 1.004– 1.104, P = 0.033) were risk factors for lower ASMI, but the risk of lower ASMI was decreased by 32% (95% CI: 0.5744– 0.804, P = 0.000) by elevated BMI in the overweight and obese group (Group C and Group D). Conclusion: The prevalence of sarcopenia and abdominal obesity was elevated in han Chinese middle-aged and elderly patients with T2DM. Being overweight or obesity as defined by BMI protect against sarcopenia, while abdominal obesity increases the risk of sarcopenia. Keywords: T2DM, sarcopenia, ASMI, BMI, WC Type 2 diabetes mellitus (T2DM) has reached a common chronic metabolic disease, becoming a key public health and research priorities worldwide. T2DM occurs due to various factors that cause insulin resistance and β-cell dysfunction. 1 The latest research data suggest 18.80% prevalence rate of T2DM in the Chinese individuals aged ≥65 years, and the incidence of diabetes in the elderly is increasing. 2 A total of 41.0% and 24.3% of Chinese diabetic patients are overweight and obesity, respectively. 3 Sarcopenia is a degenerative disease characterized by loss of skeletal muscle mass, low muscle strength or low physical performance, with the risk of falls, frailty, fractures, disability, hospitalization and death. 4,5 Moreover, it increases the risk of developing chronic metabolic diseases, 6 which seriously affect the health status and quality of life in the elderly. At present, the understanding of sarcopenia is still unclear. Therefore, it is necessary to identify the high-risk groups in the whole life process and seek the opportunity and measures for early prevention and intervention. Sarcopenia and T2DM are both common diseases in a growing ageing population, and their interaction and influence have been received growing interest over the last decade. 7 Chronic hyperglycemia causes damage to the skeletal muscles, has been described as a new complication in diabetic patients in the literature. 8 Recent meta-analyses indicated that the prevalence of sarcopenia was significantly elevated in elderly patients with T2DM. Patients showed a greater decline in muscle mass, muscle strength, and functional capacity with aging. 6 Sarcopenic obesity is a new category of obesity in older adults who have high adiposity coupled with low muscle mass. Sarcopenia often coexists with obesity. 9 There is controversy surrounding the effects of obesity as measured by body mass index (BMI) in elderly with sarcopenia. 9 Previous studies reported negative associations between overweight/obesity defined by high BMI and sarcopenia. 10 A Japanese study found elderly diabetes patients with low BMI and high body fat mass may be more likely to develop sarcopenia. 11 However, a previous stud -Abstract Truncated-
endocrinology & metabolism